Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of MPD-1 in Patients With Advanced Solid Tumor

Clinical trial NCT06944457 · RECRUITING

Trial details

NCT number: NCT06944457
Sponsor: Pharosgen Co.,Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer Solid Tumor Cancer Biomarkers

Start date: 2024-12-10
Primary completion: 2026-12-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.